Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Science for Life Laboratory, National Resource for Mass Spectrometry Imaging, Uppsala University, Uppsala, Sweden.
Nat Methods. 2019 Oct;16(10):1021-1028. doi: 10.1038/s41592-019-0551-3. Epub 2019 Sep 23.
We present a mass spectrometry imaging (MSI) approach for the comprehensive mapping of neurotransmitter networks in specific brain regions. Our fluoromethylpyridinium-based reactive matrices facilitate the covalent charge-tagging of molecules containing phenolic hydroxyl and/or primary or secondary amine groups, including dopaminergic and serotonergic neurotransmitters and their associated metabolites. These matrices improved the matrix-assisted laser desorption/ionization (MALDI)-MSI detection limit toward low-abundance neurotransmitters and facilitated the simultaneous imaging of neurotransmitters in fine structures of the brain at a lateral resolution of 10 µm. We demonstrate strategies for the identification of unknown molecular species using the innate chemoselectivity of the reactive matrices and the unique isotopic pattern of a brominated reactive matrix. We illustrate the capabilities of the developed method on Parkinsonian brain samples from human post-mortem tissue and animal models. The direct imaging of neurotransmitter systems provides a method for exploring how various neurological diseases affect specific brain regions through neurotransmitter modulation.
我们提出了一种质谱成像(MSI)方法,用于全面绘制特定脑区的神经递质网络。我们基于氟甲基吡啶鎓的反应基质促进了含有酚羟基和/或伯或仲胺基团的分子的共价电荷标记,包括多巴胺能和血清素能神经递质及其相关代谢物。这些基质提高了基质辅助激光解吸/电离(MALDI)-MSI 对低丰度神经递质的检测限,并促进了在 10μm 的横向分辨率下对大脑精细结构中的神经递质进行同时成像。我们展示了使用反应基质的固有化学选择性和溴化反应基质的独特同位素模式来鉴定未知分子种类的策略。我们在来自人类死后组织和动物模型的帕金森病脑样本上说明了所开发方法的能力。神经递质系统的直接成像提供了一种方法,可以通过神经递质调节来探索各种神经疾病如何影响特定的脑区。